文献速递眼整形与眼眶神经眼科

IL-17A通过CD40-CD40L结合在甲状腺相关眼病眼眶成纤维细胞中促进RANTES而非IL-16表达

IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2016-01-01

研究检测甲状腺相关眼病(TAO)患者外周血及眼眶组织中IL-17A、IFN-γ、RANTES和IL-16水平,并观察IL-17A联合CD40L对原代眼眶成纤维细胞表达RANTES与IL-16及凋亡的影响,发现IL-17A可协同CD40L增强RANTES表达但不影响IL-16,且不促进明显凋亡。

要点

  • TAO患者血清IL-17A、IFN-γ、RANTES和IL-16水平升高,外周血产生IL-17A和IFN-γ的T细胞频率增加。
  • TAO眼眶组织富含T淋巴细胞,IL-17A、IFN-γ、RANTES和IL-16表达增多。
  • IL-17A联合CD40L可增强原代眼眶成纤维细胞RANTES表达,但不增强IL-16表达,且不促进明显凋亡。

核心结论

  • IL-17A诱导眼眶成纤维细胞RANTES表达具有有效作用,为理解Th17细胞在TAO病理中的作用及其作为TAO和其他自身免疫病免疫治疗靶点的潜力提供了可能机制。

研究设计与样本

  • 研究获取TAO患者与健康对照的血样进行ELISA和流式细胞术分析。
  • 从手术废弃组织培养原代人眼眶成纤维细胞,在有或无CD40L条件下用IL-17A刺激,并行qRT-PCR、ELISA、Western blotting和凋亡检测。

主要发现

  • 与健康对照相比,TAO患者血清IL-17A、IFN-γ、RANTES和IL-16水平升高,外周血单核细胞中产生IL-17A和IFN-γ的T细胞频率增加。
  • TAO眼眶组织富含T淋巴细胞,表达更多IL-17A、IFN-γ、RANTES和IL-16。
  • IL-17A与CD40L协同可增强培养原代眼眶成纤维细胞RANTES表达,但不增强IL-16表达。
  • MAPK信号在很大程度上介导IL-17A处理眼眶成纤维细胞的RANTES产生。
  • IL-17A不能促进TAO患者与健康对照眼眶成纤维细胞的明显凋亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This present study aims to investigate the phenotype of IL-17A-producing T cells in thyroid-associated ophthalmopathy (TAO) and the role of IL-17A on RANTES and IL-16 expression in orbital fibroblasts (OFs) from TAO patients. METHODS: Blood samples were obtained from TAO patients and healthy controls and were subjected to ELISA and flow cytometry analysis. Primary human OFs cultured from surgical wastes were stimulated with IL-17A in the presence or absence of CD40L and were examined by qRT-PCR, ELISA, Western blotting, and apoptosis assays. RESULTS: We reported upregulated IL-17A, IFN-γ, RANTES, and IL-16 serum levels and increased frequency of IL-17A- and IFN-γ-producing T cells in peripheral blood mononuclear cells from patients with TAO compared with healthy controls. In addition, TAO orbital tissues were rich in T lymphocytes, expressing more IL-17A, IFN-γ, RANTES, and IL-16. Moreover, IL-17A could enhance the expression of RANTES, but not IL-16, in cultured primary OFs in cooperation with CD40L. We further validated that MAPK signaling was largely responsible for RANTES production in IL-17A-treated OFs. Finally, we demonstrated that IL-17A could not promote apparent apoptosis in OFs from TAO patients and healthy controls. CONCLUSIONS: Our results indicate the potent effect of IL-17A-induced RANTES expression on OFs and elaborate a possible mechanism in understanding Th17 cells in the pathology of TAO and its potential as a target to immunotherapy of TAO and other autoimmune disorders.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Fang S, Huang Y, Zhong S, et al. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy. Invest Ophthalmol Vis Sci. 2016. PMID: 27832278. doi:10.1167/iovs.16-20199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。